RT Journal Article SR Electronic T1 Healthcare Asset Due Diligence: Risks and Opportunities JF The Journal of Private Equity FD Institutional Investor Journals SP 26 OP 30 DO 10.3905/jpe.2015.18.4.026 VO 18 IS 4 A1 J. Mark Pohl YR 2015 UL https://pm-research.com/content/18/4/26.abstract AB Current healthcare due diligence leaves investors with a critical blind spot: due diligence is unable to identify an intellectual property variable that determines investment outcomes. This article shows how to find that variable, discusses case studies illustrating how that variable creates or destroys value, and provides a reliable framework to assure that your due-diligence team provides guidance that is not merely correct, but effective.TOPICS: Private equity, risk management, other real assets, manager selection